Literature DB >> 21372153

Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions.

Inge Van de Walle1, Greet De Smet, Martina Gärtner, Magda De Smedt, Els Waegemans, Bart Vandekerckhove, Georges Leclercq, Jean Plum, Jon C Aster, Irwin D Bernstein, Cynthia J Guidos, Bruno Kyewski, Tom Taghon.   

Abstract

Notch signaling critically mediates various hematopoietic lineage decisions and is induced in mammals by Notch ligands that are classified into 2 families, Delta-like (Delta-like-1, -3 and -4) and Jagged (Jagged1 and Jagged2), based on structural homology with both Drosophila ligands Delta and Serrate, respectively. Because the functional differences between mammalian Notch ligands were still unclear, we have investigated their influence on early human hematopoiesis and show that Jagged2 affects hematopoietic lineage decisions very similarly as Delta-like-1 and -4, but very different from Jagged1. OP9 coculture experiments revealed that Jagged2, like Delta-like ligands, induces T-lineage differentiation and inhibits B-cell and myeloid development. However, dose-dependent Notch activation studies, gene expression analysis, and promoter activation assays indicated that Jagged2 is a weaker Notch1-activator compared with the Delta-like ligands, revealing a Notch1 specific signal strength hierarchy for mammalian Notch ligands. Strikingly, Lunatic-Fringe- mediated glycosylation of Notch1 potentiated Notch signaling through Delta-like ligands and also Jagged2, in contrast to Jagged1. Thus, our results reveal a unique role for Jagged1 in preventing the induction of T-lineage differentiation in hematopoietic stem cells and show an unexpected functional similarity between Jagged2 and the Delta-like ligands.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21372153      PMCID: PMC3673751          DOI: 10.1182/blood-2010-06-290049

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  55 in total

1.  Fringe differentially modulates Jagged1 and Delta1 signalling through Notch1 and Notch2.

Authors:  C Hicks; S H Johnston; G diSibio; A Collazo; T F Vogt; G Weinmaster
Journal:  Nat Cell Biol       Date:  2000-08       Impact factor: 28.824

2.  Characterization in vitro and engraftment potential in vivo of human progenitor T cells generated from hematopoietic stem cells.

Authors:  Génève Awong; Elaine Herer; Charles D Surh; John E Dick; Ross N La Motte-Mohs; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2009-06-02       Impact factor: 22.113

Review 3.  Notch signaling in the immune system.

Authors:  Freddy Radtke; Nicolas Fasnacht; H Robson Macdonald
Journal:  Immunity       Date:  2010-01-29       Impact factor: 31.745

4.  Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1.

Authors:  K Ohishi; B Varnum-Finney; D Flowers; C Anasetti; D Myerson; I D Bernstein
Journal:  Blood       Date:  2000-05-01       Impact factor: 22.113

Review 5.  Regulation of Notch signaling during T- and B-cell development by O-fucose glycans.

Authors:  Pamela Stanley; Cynthia J Guidos
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

6.  Dynamic regulation of notch 1 and notch 2 surface expression during T cell development and activation revealed by novel monoclonal antibodies.

Authors:  Emma Fiorini; Estelle Merck; Anne Wilson; Isabel Ferrero; Wei Jiang; Ute Koch; Floriane Auderset; Elisa Laurenti; Fabienne Tacchini-Cottier; Michel Pierres; Freddy Radtke; Sanjiv A Luther; H Robson Macdonald
Journal:  J Immunol       Date:  2009-11-13       Impact factor: 5.422

Review 7.  Notch signaling in the hematopoietic system.

Authors:  Ashley R Sandy; Ivan Maillard
Journal:  Expert Opin Biol Ther       Date:  2009-11       Impact factor: 4.388

8.  Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3.

Authors:  Kang Li; Yucheng Li; Wenjuan Wu; Wendy R Gordon; David W Chang; Mason Lu; Shane Scoggin; Tihui Fu; Long Vien; Gavin Histen; Ji Zheng; Rachel Martin-Hollister; Thomas Duensing; Sanjaya Singh; Stephen C Blacklow; Zhengbin Yao; Jon C Aster; Bin-Bing S Zhou
Journal:  J Biol Chem       Date:  2008-01-08       Impact factor: 5.157

9.  The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis.

Authors:  Rui Benedito; Cristina Roca; Inga Sörensen; Susanne Adams; Achim Gossler; Marcus Fruttiger; Ralf H Adams
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

10.  Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors.

Authors:  Miguel Aste-Amézaga; Ningyan Zhang; Janet E Lineberger; Beth A Arnold; Timothy J Toner; Mingcheng Gu; Lingyi Huang; Salvatore Vitelli; Kim T Vo; Peter Haytko; Jing Zhang Zhao; Frederic Baleydier; Sarah L'Heureux; Hongfang Wang; Wendy R Gordon; Elizabeth Thoryk; Marie Blanke Andrawes; Kittichoat Tiyanont; Kimberly Stegmaier; Giovanni Roti; Kenneth N Ross; Laura L Franlin; Hui Wang; Fubao Wang; Michael Chastain; Andrew J Bett; Laurent P Audoly; Jon C Aster; Stephen C Blacklow; Hans E Huber
Journal:  PLoS One       Date:  2010-02-08       Impact factor: 3.240

View more
  37 in total

Review 1.  Notch ligand endocytosis: mechanistic basis of signaling activity.

Authors:  Abdiwahab A Musse; Laurence Meloty-Kapella; Gerry Weinmaster
Journal:  Semin Cell Dev Biol       Date:  2012-01-24       Impact factor: 7.727

Review 2.  Cytokines, Transcription Factors, and the Initiation of T-Cell Development.

Authors:  Hiroyuki Hosokawa; Ellen V Rothenberg
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

3.  RHAMM/HMMR (CD168) is not an ideal target antigen for immunotherapy of acute myeloid leukemia.

Authors:  Sylvia Snauwaert; Stijn Vanhee; Glenn Goetgeluk; Greet Verstichel; Yasmine Van Caeneghem; Imke Velghe; Jan Philippé; Zwi N Berneman; Jean Plum; Tom Taghon; Georges Leclercq; Kris Thielemans; Tessa Kerre; Bart Vandekerckhove
Journal:  Haematologica       Date:  2012-04-24       Impact factor: 9.941

4.  Characterization of the genome-wide TLX1 binding profile in T-cell acute lymphoblastic leukemia.

Authors:  K Durinck; W Van Loocke; J Van der Meulen; I Van de Walle; M Ongenaert; P Rondou; A Wallaert; C E de Bock; N Van Roy; B Poppe; J Cools; J Soulier; T Taghon; F Speleman; P Van Vlierberghe
Journal:  Leukemia       Date:  2015-06-25       Impact factor: 11.528

5.  Regulation of dendritic cell differentiation in bone marrow during emergency myelopoiesis.

Authors:  Hao Liu; Jie Zhou; Pingyan Cheng; Indu Ramachandran; Yulia Nefedova; Dmitry I Gabrilovich
Journal:  J Immunol       Date:  2013-07-05       Impact factor: 5.422

6.  Monocyte NOTCH2 expression predicts IFN-β immunogenicity in multiple sclerosis patients.

Authors:  Marsilio Adriani; Petra Nytrova; Cyprien Mbogning; Signe Hässler; Karel Medek; Poul Erik H Jensen; Paul Creeke; Clemens Warnke; Kathleen Ingenhoven; Bernhard Hemmer; Claudia Sievers; Raija Lp Lindberg Gasser; Nicolas Fissolo; Florian Deisenhammer; Zsolt Bocskei; Vincent Mikol; Anna Fogdell-Hahn; Eva Kubala Havrdova; Philippe Broët; Pierre Dönnes; Claudia Mauri; Elizabeth C Jury
Journal:  JCI Insight       Date:  2018-06-07

7.  Notch signalling stabilises boundary formation at the midbrain-hindbrain organiser.

Authors:  Kyoko Tossell; Clemens Kiecker; Andrea Wizenmann; Emily Lang; Carol Irving
Journal:  Development       Date:  2011-07-27       Impact factor: 6.868

8.  Lunatic, Manic, and Radical Fringe Each Promote T and B Cell Development.

Authors:  Yinghui Song; Vivek Kumar; Hua-Xing Wei; Ju Qiu; Pamela Stanley
Journal:  J Immunol       Date:  2015-11-25       Impact factor: 5.422

9.  A cell atlas of human thymic development defines T cell repertoire formation.

Authors:  Jong-Eun Park; Rachel A Botting; Cecilia Domínguez Conde; Dorin-Mirel Popescu; Marieke Lavaert; Daniel J Kunz; Issac Goh; Emily Stephenson; Roberta Ragazzini; Elizabeth Tuck; Anna Wilbrey-Clark; Kenny Roberts; Veronika R Kedlian; John R Ferdinand; Xiaoling He; Simone Webb; Daniel Maunder; Niels Vandamme; Krishnaa T Mahbubani; Krzysztof Polanski; Lira Mamanova; Liam Bolt; David Crossland; Fabrizio de Rita; Andrew Fuller; Andrew Filby; Gary Reynolds; David Dixon; Kourosh Saeb-Parsy; Steven Lisgo; Deborah Henderson; Roser Vento-Tormo; Omer A Bayraktar; Roger A Barker; Kerstin B Meyer; Yvan Saeys; Paola Bonfanti; Sam Behjati; Menna R Clatworthy; Tom Taghon; Muzlifah Haniffa; Sarah A Teichmann
Journal:  Science       Date:  2020-02-21       Impact factor: 47.728

10.  Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development.

Authors:  Kaat Durinck; Marieke Lavaert; Joni Van der Meulen; Anne-Catherine Dolens; Imke Velghe; Jelle De Medts; Karin Weening; Juliette Roels; Katrien De Mulder; Pieter-Jan Volders; Katleen De Preter; Tessa Kerre; Bart Vandekerckhove; Georges Leclercq; Jo Vandesompele; Pieter Mestdagh; Pieter Van Vlierberghe; Frank Speleman; Tom Taghon
Journal:  EMBO Rep       Date:  2020-04-07       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.